Hottub News

Lilly's Eloralintide Plus Tirzepatide Produced 23.3% Weight Loss in Phase 2 Trial of Adults with Type 2 Diabetes

4 reports from 4 outlets in 1 language · first reported · updated · JSON

HealthLillyEli Lilly and Company

Reports

  1. Lilly's Eloralintide Plus Tirzepatide Produced 23.3% Weight Loss in Phase 2 Trial of Adults with Type 2 Diabetesmedicaldaily.com · en ·
  2. EASD 2026: EloraTZP Bests Tirzepatide on Weight Loss, A1C in Type 2 Diabeteshcplive.com · en ·
  3. Eli Lilly and Company: Lilly's EloraTZP (combination of eloralintide and tirzepatide) delivered greater weight loss and A1C reduction vs. tirzepatide 15 mg in adults with obesity and type 2 diabetesfinanznachrichten.de · en ·
  4. Lilly's EloraTZP (combination of eloralintide and tirzepatide) delivered greater weight loss and A1C reduction vs. tirzepatide 15 mg in adults with obesity and type 2 diabetesprnewswire.com · en ·

More in Health

  1. Russian researcher ‘dies of plague released by lab accident’63 outlets
  2. Home Bargains urgent 'do not eat' warning on two popular Christmas foods46 outlets
  3. Nobel Prize week to begin with the medicine award34 outlets
  4. Russian Researcher Dies Of Plague, Hundreds Quarantined, 5 Hospitals Shut31 outlets
  5. Plague scare in Siberia’s Irkutsk after lab worker dies, 200 placed under medical observation33 outlets
  6. Donna Manton: How ketamine therapy helped an ADF veteran heal | Bega District News51 outlets